Bioinspired nanoplatforms for human-machine interfaces: Recent progress in materials and device applications.

Biotechnol Adv

Dept. of Electronic Materials Engineering, Kwangwoon University, Seoul 01897, South Korea. Electronic address:

Published: January 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The panoramic characteristics of human-machine interfaces (HMIs) have prompted the needs to update the biotechnology community with the recent trends, developments, and future research direction toward next-generation bioelectronics. Bioinspired materials are promising for integrating various bioelectronic devices to realize HMIs. With the advancement of scientific biotechnology, state-of-the-art bioelectronic applications have been extensively investigated to improve the quality of life by developing and integrating bioinspired nanoplatforms in HMIs. This review highlights recent trends and developments in the field of biotechnology based on bioinspired nanoplatforms by demonstrating recently explored materials and cutting-edge device applications. Section 1 introduces the recent trends and developments of bioinspired nanomaterials for HMIs. Section 2 reviews various flexible, wearable, biocompatible, and biodegradable nanoplatforms for bioinspired applications. Section 3 furnishes recently explored substrates as carriers for advanced nanomaterials in developing HMIs. Section 4 addresses recently invented biomimetic neuroelectronic, nanointerfaces, biointerfaces, and nano/microfluidic wearable bioelectronic devices for various HMI applications, such as healthcare, biopotential monitoring, and body fluid monitoring. Section 5 outlines designing and engineering of bioinspired sensors for HMIs. Finally, the challenges and opportunities for next-generation bioinspired nanoplatforms in extending the potential on HMIs are discussed for a near-future scenario. We believe this review can stimulate the integration of bioinspired nanoplatforms into the HMIs in addition to wearable electronic skin and health-monitoring devices while addressing prevailing and future healthcare and material-related problems in biotechnologies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biotechadv.2023.108297DOI Listing

Publication Analysis

Top Keywords

bioinspired nanoplatforms
20
trends developments
12
bioinspired
9
human-machine interfaces
8
device applications
8
hmis
8
bioelectronic devices
8
nanoplatforms hmis
8
applications
5
nanoplatforms
5

Similar Publications

Non-small cell lung cancer (NSCLC) remains one of the most lethal malignancies worldwide, highlighting the urgent need for the development of novel multifunctional therapeutic strategies. In this study, a bioinspired nanocomposite drug delivery system was designed and constructed by covalently modifying propylene glycol alginate (PGA) with a microbial-derived coumarin compound (Compound 1) and a fluorinated small molecule (Compound 2), followed by assembly with the silane-based crosslinker ATPMS. The system was subsequently loaded with Dendrobium extract to produce the final nanocomposite material, 2-PGA-1-ATPMS@Dendrobium.

View Article and Find Full Text PDF

Advances in nanotechnology-based thrombopoietic therapies: trends, challenges, and future directions.

Int J Pharm

August 2025

Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, 391760, Gujarat, India; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. Electronic address: bhupendra.prajapati40731@p

Thrombocytopenia, characterized by abnormally low platelet counts, remains a significant clinical challenge with limited and often suboptimal treatment options. Conventional therapies such as thrombopoietin analogs, interleukins, and platelet transfusions are constrained by immunogenicity, cost, and inconsistent efficacy. Recent advances in nanotechnology have opened transformative avenues for thrombopoietic therapy, offering targeted delivery systems, enhanced bioavailability, and improved therapeutic outcomes.

View Article and Find Full Text PDF

The unsatisfactory delivery efficacy of nanocarriers adversely restricts the therapeutic activity of encapsulated cargoes, and the current strategies, such as ligand decoration, is limited by the tumor heterogeneity of patients. Inspired by the excellent adhesion behavior of mussels, we developed a nanocarrier (Ac-NP) of catechol-decorated hyperbranched polyglycerol (HPG) to enable strong anchoring to ECM components (collagen I, laminin, proteoglycans), markedly improving the delivery efficacy of various anticancer agents. Meanwhile, to minimize its nonspecific ECM anchoring following intravenous injection, the nanocarrier was masked by 4-carboxyphenylboronic acid (PBA), and the resultant TAc-NPs exhibited specific tumor extracellular ECM-anchoring capability.

View Article and Find Full Text PDF

Functionalized inorganic nanoparticles (NPs) intrinsically radiolabeled with theranostic radiometals hold the potential to revolutionize cancer management. The appropriate choice of the radiometal used in the nanoplatform would not only aid in the diagnosis and staging of the disease but also facilitate them becoming an integral part of the therapeutic regimen, either as an independent treatment or in combination with other conventional modalities. Furthermore, due to the inherent characteristics of the NPs, such systems can demonstrate potential in multimodality imaging to offer improved diagnostic and therapeutic monitoring abilities for personalized treatment.

View Article and Find Full Text PDF

The emerging paradigm of bioinspired nanomedicine, exemplified by lipid nanoparticles and cellular drug carriers, has opened new avenues for targeting inaccessible tissues. Building on these advances, we present a platelet-hitchhiking nanoplatform engineered to overcome the blood-brain barrier (BBB) by leveraging vascular injury-responsive mechanisms. Recognizing the neuroprotective potential of thyroid hormones during ischemic crises, we designed fucoidan-decorated lipid nanoparticles (T-T3) that actively target P-selectin on activated platelets-molecular sentinels of cerebrovascular damage.

View Article and Find Full Text PDF